TY  - GEN
AU  - Ruperto,Nicolino
AU  - Quartier,Pierre
AU  - Wulffraat,Nico
AU  - Woo,Patricia
AU  - Ravelli,Angelo
AU  - Mouy,Richard
AU  - Bader-Meunier,Brigitte
AU  - Vastert,Sebastiaan J
AU  - Noseda,Emanuele
AU  - D'Ambrosio,Daniele
AU  - Lecot,Jean
AU  - Chakraborty,Abhijit
AU  - Martini,Alberto
AU  - Chioato,Andrea
TI  - A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
SN  - 1529-0131
PY  - 2012///0913
KW  - Adolescent
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antirheumatic Agents
KW  - Arthritis, Juvenile
KW  - drug therapy
KW  - Child
KW  - Child, Preschool
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Interleukin-1beta
KW  - antagonists & inhibitors
KW  - Male
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/art.33342
ER  -